About Meso Numismatics

Meso Numismatics, Inc. engages in the numismatic business. Since the acquisition of Global Stem Cell Group in 2021, the company’s focus has been mainly dedicated to its operations serving the markets in the regenerative medicine industry. The company work with doctors and their staff to provide products, solutions, equipment, services, and training to help them be successful in the application of Stem Cell Therapies. The company’s team combines solutions from extensive clinical research with the manufacturing and commercialization of viable cell therapy and immune support related products that will change the course of traditional medicine around the world forever. The company’s strategy allows it the ability to create immediate revenue streams through product sales, distribution, and clinical applications, driven by its extensive education platform. The company’s revenue comes directly from the training and the seminars, from the resale of these kits, products, and equipment, services, and from the reoccurring application of its process using the kits and solutions it provides. Products Solidifying and increasing its presence worldwide www.cellgenic.com, the company is completing its new catalog of Cell Therapy products manufactured completely in house as opposed of its previous re seller model. This new series of products include: CELLGENIC FLOW EXOSOMES: This is the company’s flagship product, which stands ready to revolutionize the practice of regenerative medicine. Exosomes are extracellular vesicles that float freely within the blood, very much like platelets. These are cell-derived non-particles that play a pivotal role in cell-to-cell communication that are involved in a wide range of physiological processes. Exosomes play an important role in the transfer of proteins and other bioactive molecules between cells and regulate gene expression in recipient cells, thus influencing various molecular pathways and have a wide range of therapeutic implications, including hair loss and pain management. CELLGENIC MSC (Mesenchymal Stem Cell): This product excretes growth factors, cytokines, and proteins, which all play a key role in the regeneration of tissue. Their anti-inflammatory and immunomodulatory properties mean that it is difficult for them to be rejected by the body. Additionally, they increase blood flow to the vital organs that need it the most. MSC has immunomodulatory effects that have an effect on macrophages, neutrophils, NK cells, mast cells and dendritic cells in innate immunity with known anti-inflammatory benefits. CELLGENIC LUMA (Lyophilized Exosomes) is derived from human umbilical cord mesenchymal stem cells and includes potent growth factors, peptides, coenzymes, minerals, amino acids, vitamins and UV radiation reducing agents for skin revitalization. Exosomes are extracellular vesicles, which is the medical term for tiny bubbles that are released from stem cells. Exosomes carry genetic information and proteins to cells throughout your body, and they create paths for communication between cells to help combat aging skin, environmental damage and loss of elasticity and tone. VITANOVAS is a mobile IV infusion company that provides in-home treatments to patients in need of immune modulation to help fight infections, viruses, and diseases. GCELL RESTORE GCell technology is a closed-system medical device that harnesses the natural and powerful restorative capabilities of adipose tissue. It is a cutting-edge tool that utilizes micrograft technology to harness the natural and powerful restorative capabilities of adipose tissues. This is a precise system that is able to process a stem cell sample from adipose tissue in less than half of the time that it would take a physician to do so through traditional means. This allows the patient to be more comfortable throughout the shorter procedure, as less anesthesia is also required than when operating under traditional means. The GCell is a minimally invasive, portable machine that allows physicians to fully unlock the potential of regenerative medicine as a component in their practice. CELLGENIC SVF is an isolation kit system that has all the ingredients and consumables for the extraction of adipose-Derived Stem cells from fat. This complete kit it is being used in clinical procedures for lung disease, intra-articular injections for osteoarthritis of the knee and hip, cosmetic surgery, dermal injection, stem cell enriched fat transfer, wounds chronic ulcers among other chronic conditions. CELLGENIC BONE MARROW Cell isolation protocols usually include density gradient centrifugation. With careful attention to detail the BMC system gently and precisely processes bone marrow aspirate for the purest concentration of these cells at the point of care. BMC is part of a developmental effort to provide an effective therapy that is low risk. It recovers a large percentage of platelet rich plasma and other total nucleated cells in a treatment sample. It is a closed system with strong performance outcomes and outstanding product stability. CELLGENIC PRP (Platelet Rich Plasma) is used to encourage healing and reduce inflammation. As a concentrated source of autologous platelets, PRP contains several growth factors and other cytokines that can stimulate the healing of soft tissues. Marketing Global Stem Cell Group, Inc. uses its vast network of professionals in the regenerative and therapeutic industries to market and grow the company’s business. Training seminars held on location in more than a dozen international locations have helped drive the attraction that is bringing new business to the company. The ISCCA (International Society for Stem Cell Application) is the company’s professional association and is a global network of medical professionals that leverages these multinational relationships to build best practices and further the company’s mission. The company’s physician training services educate and generate continued reoccurring demand for its solutions, services, and products. Patents and Proprietary Rights The company’s business includes the development of proprietary cell therapy products, as well as revenue generating physician and patient based regenerative medicine / cell therapy training services, cell collection and cell storage services, the sale of cell collection and treatment kits for humans and animals, and the operation of a cell therapy clinic. On February 19, 2019, the U.S. Patent and Trademark Office (USPTO) filed U.S. service trademark, 5,682,488 which claims exclusive the company’s of ‘ISCCA’ as INTERNATIONAL SOCIETY FOR STEM CELL APPLICATION to Stem Cell Training Inc a Florida Corporation. On April 30, 2019, the U.S. Patent and Trademark Office (USPTO) granted U.S. service trademark, 5,739,089 which claims exclusive the company’s of ‘ISCCA’ as INTERNATIONAL SOCIETY FOR STEM CELL APPLICATION to Stem Cell Training Inc a Florida Corporation. The company owns proprietary protocols for the harvesting and isolation of Stem Cells Derived from the adipose tissue and Bone marrow. The company also owns proprietary standard operating procedures for the manufacturing of allogeneic cellular therapy products derived from perinatal tissue. History The company was founded in 1999. It was incorporated under the laws of the state of Nevada in 2001. The company was formerly known as Pure Hospitality Solutions, Inc. and changed its name to Meso Numismatics, Inc. in 2018.